x vivo gene therapy
Gene therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2013 (NCT01855685)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Cytochrome b-245 heavy chainSupplementation
CYBB supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- x vivo gene therapy
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02757911 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2016 | Genethon, University of Paris |
| NCT01855685 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2013 | Genethon, J. W. Goethe University, University of London |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genethon | For profit | 2 | 2 | 1 | 2013 |
| J. W. Goethe University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Paris | Academic/Hospital | 1 | 0 | 1 | 2016 |
4 organizations
Page 1 / 1